Linde PLC (LIN) Receives €186.43 Consensus PT from Brokerages
Linde PLC (ETR:LIN) has received an average recommendation of “Hold” from the eighteen brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is €186.43 ($216.78).
Several equities research analysts recently weighed in on the stock. UBS Group restated a “buy” rating on shares of Linde in a research report on Monday, February 18th. Sanford C. Bernstein restated a “sell” rating on shares of Linde in a research report on Friday, March 1st. Deutsche Bank restated a “buy” rating on shares of Linde in a research report on Monday, March 4th. Jefferies Financial Group restated a “buy” rating on shares of Linde in a research report on Monday, March 4th. Finally, Baader Bank restated a “neutral” rating on shares of Linde in a research report on Monday, March 4th.
Shares of LIN opened at €154.40 ($179.53) on Thursday. Linde has a fifty-two week low of €130.75 ($152.03) and a fifty-two week high of €191.80 ($223.02). The firm has a market capitalization of $86.18 billion and a P/E ratio of 31.26. The company has a current ratio of 0.86, a quick ratio of 0.64 and a debt-to-equity ratio of 123.14.
Linde plc operates as an industrial gas and engineering company. The company offers oxygen, nitrogen, argon, rare gases, carbon monoxide, carbon dioxide, helium, hydrogen, electronic gases, specialty gases, acetylene, shielding gases, and noble gases, as well as develops and distributes procedures and systems for gas applications.
Further Reading: How to calculate the intrinsic value of a stock
Receive News & Ratings for Linde Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde and related companies with MarketBeat.com's FREE daily email newsletter.